SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001171843-23-001045
Filing Date
2023-02-17
Accepted
2023-02-17 16:47:48
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM F-3 f3_021623.htm F-3 439307
2 EXHIBIT 1.2 exh_12.htm EX-1.2 273770
3 EXHIBIT 5.1 exh_51.htm EX-5.1 27179
4 EXHIBIT 5.2 exh_52.htm EX-5.2 44494
5 EXHIBIT 23.1 exh_231.htm EX-23.1 1941
6 CALCULATION OF FILING FEE TABLES exh_107.htm EX-FILING FEES 18783
7 GRAPHIC logo.jpg GRAPHIC 7288
8 GRAPHIC mccarthy_logo2.jpg GRAPHIC 5355
9 GRAPHIC mccarthy_logo.jpg GRAPHIC 3355
10 GRAPHIC mccarthy_logo3.jpg GRAPHIC 1821
11 GRAPHIC mintz.jpg GRAPHIC 8513
12 GRAPHIC pricewaterhousecoopers_logo.jpg GRAPHIC 2695
  Complete submission text file 0001171843-23-001045.txt   847274
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: F-3 | Act: 33 | File No.: 333-269868 | Film No.: 23643451
SIC: 2834 Pharmaceutical Preparations